CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Revenue
Transformation	[1]	$ 10,235	$ 8,114
Platform and operations	[1]	96,003	41,335
Total revenue		106,238	49,449
Expenses
Cost of revenues (exclusive of depreciation and amortization expenses presented separately below)	[1]	67,528	28,610
Selling, general and administrative expenses	[1]	53,550	31,946
Depreciation and amortization expenses		6,615	3,371
Goodwill impairment		0	160,600
Total operating expenses		127,693	224,527
Operating income (loss)		(21,455)	(175,078)
Interest income		185	279
Interest expense		(954)	0
Income (loss) from affiliates		(522)	0
Other income (expense), net		2	0
Income (loss) before income taxes and non-controlling interests		(22,744)	(174,799)
Provision (benefit) for income taxes		405	(988)
Net income (loss)		(23,149)	(173,811)
Net income (loss) attributable to non-controlling interests		(5,137)	(51,071)
Net income (loss) attributable to Evolent Health, Inc.		(18,012)	(122,740)
Earnings (Loss) Available for Common Shareholders
Basic		(18,012)	(122,740)
Diluted		$ (18,012)	$ (122,740)
Earnings (Loss) per Common Share
Basic (in dollars per share)		$ (0.34)	$ (2.91)
Diluted (in dollars per share)		$ (0.34)	$ (2.91)
Weighted-Average Common Shares Outstanding
Basic (in shares)		52,599	42,185
Diluted (in shares)		52,599	42,185
Affiliates
Revenue
Transformation		$ 198	$ 44
Platform and operations		6,778	7,002
Expenses
Cost of revenues (exclusive of depreciation and amortization expenses presented separately below)		6,344	5,128
Selling, general and administrative expenses		$ 405	$ 383

[1] Amounts related to affiliates included above are as follows (see Note 16): (1) Amounts related to affiliates included above are as follows (see Note 16):RevenueTransformation$198$44Platform and operations6,7787,002ExpensesCost of revenue (exclusive of depreciation and amortization expenses)6,3445,128Selling, general and administrative expenses405383